The story in Ind Swift labs seems to be over as Ranbaxy Limited lost the case on Lipitor all over the world. Ind Swift lab was to supply its main product viz. lipitor to ranbaxy
Tip from friend and I looked for icicidirect research and it show that we can look into.
Please guruji give you thought
Buy ashok leyland at cmp target 44-45 with 1/4 part of capital. strong support at 40.